Although Vought International had begun taking preorders for Compound V on its official website, the price put it far beyond the reach of most people.
A single dose of Compound V cost a staggering six million dollars.
Most people would never earn that much in their lifetime.
To keep the number of buyers from overwhelming its servers when sales opened, Vought International required real-name registration for the presale. Every prospective buyer had to provide personal information and pay a deposit of five hundred thousand dollars.
Vought International would refund the deposit to the original account of anyone who failed to secure a dose of Compound V.
That deposit was enough to deter almost everyone who had only wanted to join in the excitement.
Vought International was releasing one thousand doses of Compound V. If the limited sale went smoothly, it would bring in six billion dollars in one go.
And this was only Vought International's first tentative step.
No one knew how much Compound V could be produced. Perhaps making it was so difficult that even Vought International could produce only a limited amount, forcing the company to release a small number of doses at a time.
Or perhaps Compound V could easily be mass-produced, and its high price came solely from Vought International's monopoly on the formula.
It was like diamonds. Once a monopoly was in place, those who held it could set whatever price they liked. Diamonds themselves were hardly rare, but slick promotion and deliberately restricted supply had made them a luxury whose price bore little relation to its value.
Whatever the process for making Compound V, Vought International controlled it completely. Whether the company was using scarcity to drive up the price or simply lacked the capacity to sell more, the price was set, regardless of